Bausch + Lomb (BLCO) News Today $11.94 -0.31 (-2.49%) Closing price 04/15/2025 03:59 PM EasternExtended Trading$11.95 +0.00 (+0.04%) As of 04/15/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Trexquant Investment LP Sells 46,127 Shares of Bausch + Lomb Co. (NYSE:BLCO)Trexquant Investment LP reduced its position in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 70.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 19,147 shares of the company's stock after selling 46,127 shares during the quarter. Trexquant InvesApril 15 at 3:40 AM | marketbeat.comBausch + Lomb recalls lenses used in cataract surgery due to inflammatory reactionsApril 11, 2025 | msn.comBausch + Lomb (NYSE:BLCO) Reaches New 1-Year Low - Here's What HappenedBausch + Lomb (NYSE:BLCO) Sets New 12-Month Low - Here's WhyApril 11, 2025 | marketbeat.comBronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb (BLCO) And Encourages Shareholders to ConnectApril 9, 2025 | markets.businessinsider.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb (BLCO) And Encourages Shareholders to Reach OutApril 8, 2025 | markets.businessinsider.comYakira Capital Management Inc. Makes New Investment in Bausch + Lomb Co. (NYSE:BLCO)Yakira Capital Management Inc. purchased a new stake in Bausch + Lomb Co. (NYSE:BLCO - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 23,334 shares of the company's stock, valued at approximateApril 8, 2025 | marketbeat.com48,228 Shares in Bausch + Lomb Co. (NYSE:BLCO) Acquired by Dynamic Technology Lab Private LtdDynamic Technology Lab Private Ltd bought a new stake in Bausch + Lomb Co. (NYSE:BLCO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 48,228 shares of the company's stock, valued at approximatApril 8, 2025 | marketbeat.comExodusPoint Capital Management LP Reduces Stock Holdings in Bausch + Lomb Co. (NYSE:BLCO)ExodusPoint Capital Management LP cut its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 60.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 366,721 shares of the company's stock after selling 557,760 shares during the quarterApril 7, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Given New $17.00 Price Target at Royal Bank of CanadaRoyal Bank of Canada decreased their price target on shares of Bausch + Lomb from $18.00 to $17.00 and set an "outperform" rating on the stock in a research note on Friday.April 6, 2025 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Shares Purchased by Cinctive Capital Management LPCinctive Capital Management LP increased its holdings in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 114.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 96,696 shares of the company's stock after pApril 6, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Sets New 12-Month Low After Analyst DowngradeBausch + Lomb (NYSE:BLCO) Reaches New 12-Month Low After Analyst DowngradeApril 5, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Price Target Lowered to $15.00 at Stifel NicolausStifel Nicolaus decreased their price target on Bausch + Lomb from $17.00 to $15.00 and set a "hold" rating for the company in a report on Thursday.April 5, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Purchases 414,138 Shares of Bausch + Lomb Co. (NYSE:BLCO)Arrowstreet Capital Limited Partnership boosted its position in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 51.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,218,431 shares of the company's stock after buyinApril 5, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Reaches New 52-Week Low on Analyst DowngradeBausch + Lomb (NYSE:BLCO) Reaches New 1-Year Low After Analyst DowngradeApril 5, 2025 | marketbeat.comRBC Capital senkt Kursziel für Bausch & Lomb auf 17 US-Dollar, behält Outperform-Rating beiApril 4, 2025 | de.investing.comBronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb (BLCO) And Encourages Investors to ConnectApril 4, 2025 | markets.businessinsider.comWells Fargo Downgrades Bausch + Lomb (BLCO)March 30, 2025 | msn.comRaymond James Financial Inc. Invests $2.84 Million in Bausch + Lomb Co. (NYSE:BLCO)Raymond James Financial Inc. purchased a new stake in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 157,454 shares of the company's stock, valuMarch 30, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Trading Down 6.7% - Should You Sell?Bausch + Lomb (NYSE:BLCO) Stock Price Down 6.7% - Here's WhyMarch 29, 2025 | marketbeat.comWells Fargo & Company Reiterates Equal Weight Rating for Bausch + Lomb (NYSE:BLCO)Wells Fargo & Company reissued an "equal weight" rating and issued a $15.00 target price (down from $24.00) on shares of Bausch + Lomb in a report on Friday.March 29, 2025 | marketbeat.comWF downgrades Bausch + Lomb on enVista recall giving a near-term uncertaintyMarch 28, 2025 | finance.yahoo.comBausch + Lomb Stock Sinks on 'Voluntary Recall' of Some Implantable Eye LensesMarch 28, 2025 | msn.comWhy Bausch + Lomb (BLCO) Shares Are Plunging TodayMarch 28, 2025 | msn.comBausch + Lomb (NYSE:BLCO) Shares Gap Down - Here's What HappenedBausch + Lomb (NYSE:BLCO) Shares Gap Down - Here's WhyMarch 28, 2025 | marketbeat.comBausch + Lomb downgraded to Equal Weight from Overweight at Wells FargoMarch 28, 2025 | markets.businessinsider.comBausch + Lomb cut to Equal Weight at Wells Fargo following enVista recallMarch 28, 2025 | markets.businessinsider.comWhy Bausch + Lomb (BLCO) Stock Is NosedivingMarch 27, 2025 | msn.comBausch + Lomb shares fall on voluntary recallMarch 27, 2025 | in.investing.comBausch + Lomb recalls several brands of enVista intraocular lensesMarch 27, 2025 | msn.comBausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30March 26, 2025 | businesswire.comBausch + Lomb Co. (NYSE:BLCO) Given Consensus Rating of "Hold" by AnalystsShares of Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) have earned an average rating of "Hold" from the twelve brokerages that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and five haMarch 21, 2025 | marketbeat.comRaymond James sees positive reaction in Bausch Health shares in next daysMarch 20, 2025 | markets.businessinsider.comBausch + Lomb announces U.S. launch of lens fitting system Arise for Ortho-kMarch 17, 2025 | markets.businessinsider.comBausch + Lomb Launches Arise™ Orthokeratology Lens System in the United StatesMarch 17, 2025 | finance.yahoo.comBausch + Lomb Co. (NYSE:BLCO) Sees Large Growth in Short InterestBausch + Lomb Co. (NYSE:BLCO - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 1,860,000 shares, an increase of 52.5% from the February 13th total of 1,220,000 shares. Currently, 5.2% of the company's stock are short sold. Based on an average daily volume of 631,100 shares, the days-to-cover ratio is presently 2.9 days.March 16, 2025 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Shares Sold by River Road Asset Management LLCRiver Road Asset Management LLC decreased its stake in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 25.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,506,986 shares of the company's stock after selling 513,428 shMarch 11, 2025 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Shares Sold by Clark Estates Inc. NYClark Estates Inc. NY lowered its holdings in Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 12.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 600,000 shares of the company's stock after selling 87,500 shares duriMarch 5, 2025 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Short Interest Down 29.5% in FebruaryBausch + Lomb Co. (NYSE:BLCO - Get Free Report) was the target of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 1,220,000 shares, a decline of 29.5% from the January 31st total of 1,730,000 shares. Based on an average daily trading volume, of 580,500 shares, the days-to-cover ratio is currently 2.1 days. Currently, 3.4% of the shares of the company are sold short.March 3, 2025 | marketbeat.comBausch + Lomb price target lowered to $18 from $19 at Morgan StanleyFebruary 26, 2025 | msn.comBausch + Lomb Co. (NYSE:BLCO) Receives Average Rating of "Hold" from AnalystsShares of Bausch + Lomb Co. (NYSE:BLCO - Get Free Report) have been given a consensus rating of "Hold" by the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a holdFebruary 24, 2025 | marketbeat.comHC Wainwright Has Negative View of Bausch + Lomb Q1 EarningsBausch + Lomb Co. (NYSE:BLCO - Free Report) - Investment analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of Bausch + Lomb in a research report issued on Friday, February 21st. HC Wainwright analyst Y. Chen now forecasts that the company will post earningsFebruary 24, 2025 | marketbeat.comHow DOGE's 'transparency' could be applied to healthcareFebruary 23, 2025 | finance.yahoo.comNeedham Sticks to Its Hold Rating for Bausch + Lomb Corporation (BLCO)February 21, 2025 | markets.businessinsider.comBausch + Lomb (NYSE:BLCO) Price Target Cut to $18.00 by Analysts at Royal Bank of CanadaRoyal Bank of Canada dropped their price target on Bausch + Lomb from $22.00 to $18.00 and set an "outperform" rating on the stock in a research note on Thursday.February 21, 2025 | marketbeat.comBank of America Issues Pessimistic Forecast for Bausch + Lomb (NYSE:BLCO) Stock PriceBank of America decreased their target price on shares of Bausch + Lomb from $18.00 to $17.00 and set an "underperform" rating for the company in a research report on Thursday.February 21, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Given "Hold" Rating at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Bausch + Lomb in a research report on Thursday.February 21, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPSBausch + Lomb (NYSE:BLCO - Get Free Report) announced its earnings results on Wednesday. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. Bausch + Lomb had a positive return on equity of 3.17% and a negative net margin of 7.86%.February 20, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Releases Earnings Results, Beats Expectations By $0.02 EPSBausch + Lomb (NYSE:BLCO - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.23 by $0.02. Bausch + Lomb had a negative net margin of 7.86% and a positive return on equity of 3.17%.February 20, 2025 | marketbeat.comBausch + Lomb Co. (NYSE:BLCO) Shares Bought by Alberta Investment Management CorpAlberta Investment Management Corp boosted its position in shares of Bausch + Lomb Co. (NYSE:BLCO - Free Report) by 36.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,008,193 shares of the company's stockFebruary 20, 2025 | marketbeat.comBausch + Lomb price target lowered to $17 from $18 at StifelFebruary 20, 2025 | markets.businessinsider.com Remove Ads Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address BLCO Media Mentions By Week BLCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.640.78▲Average Medical News Sentiment BLCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼45▲BLCO Articles Average Week Remove Ads Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Solventum News Today Smith & Nephew News Today Penumbra News Today Stevanato Group News Today Glaukos News Today Inari Medical News Today Inspire Medical Systems News Today Soleno Therapeutics News Today iRhythm Technologies News Today PROCEPT BioRobotics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch + Lomb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLCO Stock Free BLCO Stock Alerts